Deputy director of the Iberoamerican Cochrane Centre.
Staff of the Department of Clinical Epidemiology and Public Health at the Hospital de Sant Pau
PhD in Medicine and Master’s Degree in Public Health.
Associate Professor, University School of Nursing – Hospital de Sant Pau.
Key publications:
• DianaHealth.com, an On-Line Database Containing Appraisals of the Clinical Value and Appropriateness of Healthcare Interventions: Database Development and Retrospective Analysis. Bonfill X, Osorio D, Solà I, Pijoan JI, Balasso V, Quintana MJ, Puig T, Bolibar I, Urrútia G, Zamora J, Emparanza JI, Gómez de la Cámara A, Ferreira-González I. PLoS One. 2016 Feb 3;11(2):e0147943.
• Evidence-informed recommendations to reduce dissemination bias in clinical research: conclusions from the OPEN (Overcome failure to Publish nEgative fiNdings) project based on an international consensus meeting. Meerpohl JJ, Schell LK, Bassler D, Gallus S, Kleijnen J, Kulig M, La Vecchia C, Marušić A, Ravaud P, Reis A, Schmucker C, Strech D, Urrútia G, Wager E, Antes G; OPEN project consortium. BMJ Open. 2015 May 5;5(5):e006666.
• Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS)